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In the 150 years since Semmelweis introduced the 
discipline of hospital hygiene, the discipline of hospital 
epidemiology has incorporated the germ theory, 
introduced antibiotics, applied antisepsis and, more 
recently, applied molecular biology and sophisticated 
epidemiological principles. In response to the changing 
healthcare reimbursement schemes in the United States 
and elsewhere, the discipline has also examined the 
economic implications of both nosocomial infections 
and infection control. Thus, as we approach the year 
2000, infection control is at once an art, a science and 
a business [ 11. 
To many, what the modern hospital epidemiologist 
offers an institution may not be obvious. The value of 
such a member of staff, in terms of quality of service 
compared with cost, may be unclear. This is not 
surprising as there have been a number of advances in 
infection control during the last decade and many, 
including the present authors, envisage a role for the 
hospital epidemiologist that extends beyond control of 
nosocomial infections. Thus, in this report, the role and 
value of the hospital epidemiologist are examined by 
addressing selected aspects of the control of epidemics 
and endemic nosocomial infections, economic con- 
siderations, optimal use of prescription drugs, and the 
special areas of quality assessment, travel medicine and 
employee health. As a result of training and experience, 
the modern hospital epidemiologist is uniquely quali- 
fied to manage problems in each of these areas. 
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ENDEMIC INFECTIONS 
One of the basic tasks of the hospital epidemiologist 
is surveillance and control of the endemic rate of noso- 
comial infections. Recent studies of the prevalence of 
nosocomial infections in several European countries 
have shown that, on a given day, 6.1 to 9.9% of all 
hospital patients have a hospital-acquired infection 
The Study on the Efficacy of Nosocomial In- 
fection Control (SENIC) (81 has shown that establish- 
ment of a highly effective infection control and 
surveillance program may reduce the rate of noso- 
comial infections by 13 to 38%, depending on the 
site of infection and the risk posed by particular 
characteristics of the given patient. The rate of 
infection of clean wounds may perhaps be reduced by 
76% - from 2.5% to 0.6% [9]. 
Although an increasing number of hospitals have 
implemented infection control programs, the rates of 
some noscomial infections continue to increase. The 
age-adjusted mortality due to septicemia (of which at 
least half are nosocomial) is among the 11 leading 
causes of death in the US [lo]. It must be borne in 
mind that the likelihood that an infection will occur 
is highly dependent on host susceptibility, and the 
number of susceptible patients in hospital has increased 
over the last few decades. Hospitals house high pro- 
portions of the very young or very old, and the number 
of patients who are severely immunosuppressed or in 
intensive care is higher than ever. The acquired 
immunodeficiency syndrome (AIDS) epidemic has 
brought a new kind of immunosuppressed patient to 
hospitals. These changes in the composition of patient 
groups change the types of nosocomial infection that 
are likely to arise: systemic infections due to yeast and 
molds; nosocomial cytomegalovirus (CMV) infections; 
and nosocomial cryptosporidial infections are new chal- 
lenges for the hospital epidemiologist. The emergence 
[2-71. 
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of multidrug-resistant bacteria has led to some virtually 
untreatable infections. The time during which the 
patient is infectious has become longer, and measures 
must be implemented to prevent nosocomial trans- 
mission. However, it is unlikely that nosocomial 
infections will be completely eliminated, although 
there are sufficient data to indicate that the infection 
rates in most hospitals can be reduced with the use of 
currently available knowledge and technology 1111. 
EPIDEMIC INFECTIONS 
Ongoing surveillance enables the hospital epidemio- 
logist to identify outbreaks of nosoconiial infection, 
which have been estimated to occur with a frequency 
of 1/12,000 discharges [12]. Only 2 to 4% of patients 
become infected as part of a major outbreak, and 
approximately 6% become infected as part of an 
epidemiological cluster that is not large enough to 
justif;j the term ‘outbreak’ [12,13]. Outbreaks can lead 
to serious medical, legal and administrative liability [ 141 
and, by definition, all outbreaks are preventable [15]. 
Therefore, an outbreak must be recognized as early as 
possible and thoroughly investigated, and control 
measures instituted to reduce the number of patients 
involved. 
The increasing complexity of the relationship 
between susceptible patients, the technical environ- 
ment and increasingly resistant microorganisms coni- 
plicate both the identification of sources of outbreaks 
and their control. An outbreak of resistant Pseudomonus 
cepuciu, for example, in an intensive care unit in a 
French hospital remained uncontrolled from I989 to 
1992 [16]. By 1992, up to 25% ofpatients were found 
to harbor the organism, and five patients developed 
septicemia, causing death in four. Several attempts to 
control the outbreak by additional disinfection or 
reinforcement of hygienic measures failed. Only an 
extensive investigation, including a case-control study, 
environmental sampling and ribotyping, revealed that 
the temperature sensor of the hospital ventilation 
system was the unexpected cause of the outbreak 1161. 
Epideniiologically useful microbiological tech- 
niques, such as pulsed field gel electrophoresis, ribo- 
typing and applications of the polymerase chain 
reaction, have developed at a rapid pace 117,181, and 
may lead to earlier and more frequent detection of 
epideniiological clusters and outbreaks. In the future, 
most outbreak investigations will include molecular 
analysis of the involved rnicroorganisnis 11 81. However, 
information gained by these methods must be con- 
sidered in the context of clinical, descriptive and 
investigative epidemiological knowledge. 
Estimating the cost of nosocomial infections is difficult. 
Although the direct cost (for example, extra hospital 
days due to nosocomial infection, laboratory and radio- 
graphic expenses, and costs of treatment) have been 
studied by various approaches [19-251, information 
regarding other costs, such as morbidity, pain and suf- 
fering, delayed return to work, poorer functional status 
and diminished quality of life, is rarely available [26,271. 
The additional length of stay in hospital attri- 
butable to nosocomial infection varies according to 
the site of infection and different etiological micro- 
organisms, and may be as many as 30 extra days 
[25,28,29]. The estimated annual direct cost of 
nosocomial infection in the US is at  least $4.5 
billion/year (for 1992) [30]. Wenzel and Pfaller [31] 
propose five ways to reduce the cost of hospital 
infection: reduce the incidence; reduce the morbidity 
causing prolonged illness; reduce the hospital stay; 
reduce the cost of currently effective preventative and 
control measures; and stop all ineffectual measures. In 
addition, new preventative methods should be analyzed 
as regards their cost-effectiveness before they are intro- 
duced. Nettleman and colleagues 1321, for example, 
demonstrated that the use of high-efficiency particulate 
respirators is not cost-effective in preventing trans- 
mission of tuberculosis to healthcare workers. The use 
of the respirators would have cost $7 milliodcase of 
tuberculosis prevented. 
Estiniates of the costs of nosocomial infection 
remain crude, but provide an indication of the sizc of 
the burden imposed. Recently, the costs and benefits of 
an infection-control program was compared with those 
of other preventative healthcare programs and proved 
to be among the most cost-effective [33]. However, 
most estimates are based on US data and arc not easily 
transferable to European hospitals. The different health- 
care systems in Europe may lead to highly variable 
costs due to nosocomial infection, and the extent of 
infection-control programs varies considerably from 
one country to another. Further research is needed to 
assess the influence of healthcare and infection-control 
systems on the costs of nosoconiial infection. 
DRUG USE 
During the last several decades, increasing attention has 
been paid to the developnient and spread of multidrug- 
resistant organisms in hospital, such as methicillin- 
resistant Stuphylococc~s uureus, P-lactam-resistant gram- 
negative bacilli and fluconazole-resistant Cundidu 
ulbicuns. Reports of outbreaks of vanconiycin-resistant 
enterococci [34-361 and demonstration of in-vivo 
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transfer of the resistance-codmg vanA gene 1371 raise 
the question of when will the first vancomycin-resistant 
S. aureus be detected in vivo. 
Selection of drug-resistant microorganisms has 
been associated with the widespread use of anti- 
microbial agents [38,39]. Most recently, several case- 
control studies have demonstrated that vancomycin use 
is significantly associated with infections due to vanco- 
mycin-resistant enterococci [38,40-421. The further 
spread of multidrug-resistant bacteria and of resistance- 
coding genes must be hindered to prevent the deaths of 
an increasing number of patients whose infections are 
untreatable. Implementation of measures to control 
the use of antimicrobial agents through education, a 
hospital formulary, ordering policies, control of labora- 
tory susceptibility testing and minimization of contact 
between physicians and pharmaceutical representatives 
1431 may serve to decrease the prevalence of resistant 
microorganisms 1391. 
Evaluation of the use of drugs other than anti- 
microbial agents may also improve patient care and 
outcome while reducing costs. A large study has shown 
that complications due to drug therapy were the most 
common adverse events in hospitalized patients (441. 
However, knowledge of the causes and consequences 
of the complications of drug use is scanty and must be 
enhanced. 
ASSESSMENT OF ADVERSE EVENTS 
It is now recognized that the methodology of hospital 
epidemiology can be used to assess adverse outcomes 
of medical care other than infectious events (for 
instance, falls, new events such as myocardial infarc- 
tions, strokes or skin breakdown, and complications of 
procedures). There is, as yet, no general agreement as 
to what constitutes an adverse event [45]. Studies 
carried out to assess the magnitude of the problem have 
reported different results, ranging from 1 to 20 adverse 
events/100 hospitalized patients 1451. The Harvard 
Medical Practice Study [46], a retrospective study of a 
randomized sample of 31,000 medical records, showed 
that 3.7% of patients experienced an injury due to 
medical care which was associated with death in nearly 
14% of cases. Concurrent surveillance conducted in a 
tertiary-care hospital identified rates of adverse events 
ranging from 33.9 to 39.21100 hospitalizations. These 
events resulted in adverse outcomes for 22.6 to 42.5% 
of cases with medication-related adverse events and for 
approximately 99% of cases with procedure-related 
adverse events 1471. 
As with the surveillance of nosocomial infections, 
the surveillance of adverse events allows the detection 
of clusters. A remarkable example was the epidemic of 
cardiac arrests in an intensive care unit reported in 1988 
1481. With the same epidemiological methods (case- 
control and cohort studies) typically used in the investi- 
gation of outbreaks of nosocomial infection [15,49], it 
was demonstrated that one nurse was highly associated 
with the occurrence of the cardiac arrests. The epidemic 
remained undetected for 15 months because surveil- 
lance of adverse events was not performed [48]. Other 
examples of clusters of adverse events investigated by 
hospital epidemiologists include respiratory complica- 
tions associated with receipt of a parented nutrition 
admixture [50] and anesthesia-associated carbon- 
monoxide exposure among surgical patients 1511. 
It has yet to be proved that surveillance and control 
of non-infectious adverse events and adverse outcomes 
will decrease their rate of occurrence, nor has it been 
shown that such surveillance and control programs are 
cost-effective. However, it is reasonable to assume that 
only the systematic investigation of patterns of adverse 
events will lead to the development and implemen- 
tation of rational control measures. 
TRAVEL MEDICINE 
More and more Europeans now travel to developing 
countries and, with modern air travel, they can reach 
almost any city in the world within 24 h. Recent 
reports of a plague epidemic in India and an outbreak 
of Ebola virus in Zaire 1521 raise the question of 
whether physicians are able to cope with diseases rarely 
seen in Europe. One  challenge for the hospital 
epidemiologist is to maintain awareness of any current 
infectious disease events worldwide and to establish 
guidelines for returning travelers who have com- 
municable diseases [53]. 
Physicians involved in infection control are often 
asked for travel advice. The spectrum of travel-related 
illness ranges from mild diseases, such as mild diarrhea, 
to potentially fatal diseases, such as yellow fever or 
AIDS. Travel to southern Europe carries a 25% risk of 
diarrhea whereas travel to Africa, the Middle East or 
Asia has a 20 to 60% risk [54]. Of  100,000 travelers to 
developing countries, 270 acquired an infectious 
hepatitis [55] and, statistically speaking, every airplane 
from Kenya carries one traveler who is infected with 
malaria 1561. Immunization, prophylactic medications, 
and food and water precautions help to minimize the 
risk of infection [55] and the consequent risk of 
importation of infectious diseases. 
EMPLOYEE HEALTH 
Although it has long been known that healthcare 
workers can become infected from patients, the human 
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inimunodeficiency virus (HIV) epidemic forced niany 
healthcarc workers, for the first time, to consider 
seriously the risks present in their workplace 1571. The 
risk of infection is much lower for HIV (0.3% per 
injury from HIV-positive patients [571) than for other 
blood-borne pathogens (3 to 10% per injury from 
hepatitis C-infected patients and 10 to 40% per injury 
from hepatitis B-infected patients in those who are not 
immune [SS]), but the inevitably fatal outcome and 
lack of immunization lead to major concerns with HIV 
among healthcare workers. However, the risk of 
infection from patients with blood-borne pathogens is 
low compared with other diseases (for example, 
chickenpox, viral conjunctivitis, influenza, measles, 
niumps, pertussis, parvovirus B19, respiratory syncytial 
virus, rotavirus, rubella or tuberculosis 1591). With the 
emergence of multidrug-resistant Mycobacteuium tubeu- 
culosis, this ancient scourge becomes, once again, a 
primary concern for healthcare workers. The extent of 
the risk was demonstrated by an outbreak of niultidrug- 
resistant M.  tubeuculosi.< that led to skin-test conversions 
in one-third of susceptible healthcare workers [60]. 
In niany instances, the causes of infection in the 
working place are undiagnosed patients or a lack of 
knowledge. The hospital epidemiologist needs to 
maintain a high level of suspicion to enable identi- 
fication of infected patients as soon as possible. A system 
of reporting injuries which may have resulted in contact 
with blood-borne pathogens (sharps injuries) may help 
to identify injury mechanisms that are preventable. The 
healthcare workers need to be specially educated and 
immunization progranis implemented. 
Healthcare workers are not only at risk ofbecoming 
infected in hospital, but they may also infect susceptible 
patients. A particularly tragic example was the HIV- 
positive dentist who infected three patients during 
invasive dental procedures [bl]. If healthcare workers 
are exposed to infected patients, develop a disease or 
carry an infectious agent, the hospital epidemiologist 
has to decide whether these healthcare workers should 
have further patient contact and how to prevent disease 
transmission. 
Physicians are accustomed to having one-to-one 
relationships with their patients, and their clinical 
perspective and decisions are led by their commitment 
to the given patient. In contrast, the hospital epidemio- 
logist acts from the viewpoint of the health and safety 
of whole populations [62]. With an awareness of the 
impact of a decision on the hospital population, the 
hospital epidemiologist is able to manage the comple- 
mentary interests of patients, physicians, healthcare 
workers and administrators. Thus, the methodology 
and skills of the hospital epidemiologist are not only 
applicable to nosocomial infection, but will also be of 
great value for new issues such as optimal drug use, 
assurance of quality of treatment, travel mcdicine and 
employee health. 
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